EGFR-IN-99

EGFR-IN-99 (JBJ-03-142-02) is a selective small molecule inhibitor targeting EGFR and HER2 exon 20 insertion mutations. It demonstrates potent antiproliferative activity in non-small cell lung cancer (NSCLC) cell lines and has shown efficacy in preclinical in vivo tumor models, supporting its use as a research tool for targeted oncology studies.